LPCUF (Lee's Pharmaceutical Holdings) Accounts Payable: $22.4 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LPCUF Lee's Pharmaceutical Holdings Ltd LPCUF
75 GF Score
Price $0.19
GF Value $0.28
! 5 Warning Signs
View Full Analysis

What is Lee's Pharmaceutical Holdings Accounts Payable?

Lee's Pharmaceutical Holdings LPCUF 75 Accounts Payable is $22.4 Mil as of Dec. 2025. GuruFocus rates LPCUF with a GF Score™ of 75/100 and a GF Value™ of $0.28. The stock has 5 warning signs investors should review.

Lee's Pharmaceutical Holdings's Accounts Payable for the quarter that ended in Dec. 2025 was $22.4 Mil.

Lee's Pharmaceutical Holdings's quarterly Accounts Payable declined from Dec. 2024 ($18.3 Mil) to Jun. 2025 ($17.0 Mil) but then increased from Jun. 2025 ($17.0 Mil) to Dec. 2025 ($22.4 Mil).

Lee's Pharmaceutical Holdings's annual Accounts Payable increased from Dec. 2023 ($9.5 Mil) to Dec. 2024 ($18.3 Mil) and increased from Dec. 2024 ($18.3 Mil) to Dec. 2025 ($22.4 Mil).

Lee's Pharmaceutical Holdings Accounts Payable Related Terms

Lee's Pharmaceutical Holdings Accounts Payable Historical Data

* Premium members only.

The historical data trend for Lee's Pharmaceutical Holdings's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lee's Pharmaceutical Holdings Accounts Payable Chart

Lee's Pharmaceutical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.03 13.01 9.49 18.26 22.44

Lee's Pharmaceutical Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.49 7.46 18.26 16.95 22.44
LPCUF
75GF Score
Lee's Pharmaceutical Holdings Ltd LPCUF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lee's Pharmaceutical Holdings Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $22.4 Mil mean?
Lee's Pharmaceutical Holdings (LPCUF) has a Accounts Payable of $22.4 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Lee's Pharmaceutical Holdings and its competitors.
Is Lee's Pharmaceutical Holdings' Accounts Payable too high?
Lee's Pharmaceutical Holdings' current Accounts Payable is $22.4 Mil. Overall, Lee's Pharmaceutical Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Lee's Pharmaceutical Holdings' Accounts Payable compare to ZTS and UTHR?
Lee's Pharmaceutical Holdings' Accounts Payable of $22.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Lee's Pharmaceutical Holdings and its competitors. Lee's Pharmaceutical Holdings's current Accounts Payable is $22.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lee's Pharmaceutical Holdings stock overvalued right now?
Lee's Pharmaceutical Holdings (LPCUF) has a current Accounts Payable of $22.4 Mil. The stock's GF Value™ is $0.28, compared to a current price of $0.19 — trading 32% below its estimated fair value. The current Accounts Payable is $22.4 Mil. Lee's Pharmaceutical Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Lee's Pharmaceutical Holdings (LPCUF), the current Accounts Payable is $22.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lee's Pharmaceutical Holdings (LPCUF) Overvalued in 2026?

Based on GuruFocus' analysis, Lee's Pharmaceutical Holdings stock appears to be undervalued. The current stock price of $0.19 is trading 32% below its estimated GF Value™ of $0.28.

Key valuation signals for LPCUF:

  • Accounts Payable: $22.4 Mil
  • GF Value™: $0.28 vs. price of $0.19 (32% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the LPCUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lee's Pharmaceutical Holdings Business Description

Other Exchanges 00950:Hong Kong
Address Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue; and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
75GF Score

Get the complete analysis for LPCUF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$0.28
GF Value